Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary
Authors:
- Claus F. VogelmeierCVClaus F. Vogelmeier
- Gerard J. CrinerGCGerard J. Criner
- Fernando J. MartinezFMFernando J. Martinez
- Antonio AnzuetoAAAntonio Anzueto
- Peter J. BarnesPBPeter J. Barnes
- Jean BourbeauJBJean Bourbeau
- Bartolome R. CelliBCBartolome R. Celli
- Rongchang ChenRCRongchang Chen
- Marc DecramerMDMarc Decramer
- Leonardo M. FabbriLFLeonardo M. Fabbri
- Peter FrithPFPeter Frith
- David M.G. HalpinDHDavid M.G. Halpin
Open Access
- 1 March 2017
- journal article
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 53 (3) , 128-149
Abstract
No abstract availableKeywords
This publication has 292 references indexed in Scilit:
- Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohortRespiratory Medicine, 2013
- Pulmonary Arterial Enlargement and Acute Exacerbations of COPDNew England Journal of Medicine, 2012
- Azithromycin for Prevention of Exacerbations of COPDNew England Journal of Medicine, 2011
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningNew England Journal of Medicine, 2011
- The Safety of Tiotropium — The FDA's ConclusionsNew England Journal of Medicine, 2010
- Susceptibility to Exacerbation in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2010
- Cachexia as a major underestimated and unmet medical need: facts and numbersJournal of Cachexia, Sarcopenia and Muscle, 2010
- A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2008
- A Clinical Practice Guideline for Treating Tobacco Use and Dependence: 2008 UpdateAmerican Journal of Preventive Medicine, 2008
- Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort studyThe Lancet, 2007